Adaptive Biotechnologies Corp reports results for the quarter ended December 31 - Earnings Summary

Adaptive Biotechnologies

11/02/2025 22:42

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 23 cents​​ per share for the quarter ended
December 31, higher than the same quarter last year, when the
company reported EPS of -30 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 26 cents per
share. Wall Street expected results to range from -32 cents
to -21 cents per share.
    * Revenue rose 3.7% to $47.46 million from a year ago;
analysts
expected $46.03 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 23 cents​.
    * The company reported a quarterly loss of $33.69 million.
    * Adaptive Biotechnologies Corp shares had risen by 28.1%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $7.50 
This summary was machine generated from LSEG data February 11 at
10:42 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.26          -0.23          Beat
 Sep. 30 2024      -0.29          -0.22          Beat
 Jun. 30 2024      -0.33          -0.31          Beat
 Mar. 31 2024      -0.34          -0.33          Beat